Beck M, Berger C, Filipp N, Hundertmark U, Loewel R
Z Hautkr. 1981 Aug 15;56(16):1066-70.
90 patients suffering from chronic skin diseases-mainly psoriasis vulgaris-were treated in a double-blind-study for two weeks with topical Clobetasol-17-propionate compared with other topical corticoids. In 81% was seen a better therapeutical effect on the Clobetasol-17-propionate treated skin area.
90例患有慢性皮肤病（主要是寻常型银屑病）的患者参与了一项双盲研究，他们使用丙酸氯倍他索局部用药两周，并与其他局部用皮质类固醇进行比较。在81%的患者中，观察到丙酸氯倍他索治疗的皮肤区域有更好的治疗效果。
